Cargando…
A Review of the Efficacy of Thalidomide and Lenalidomide in the Treatment of Refractory Prurigo Nodularis
Prurigo nodularis (PN) is a chronic dermatoses characterized by intensely pruritic, excoriated, or lichenified nodules. Standard therapy includes corticosteroids, antihistamines, and phototherapy; however, treatment results are often inadequate or transient. Thalidomide and its analogue lenalidomide...
Autores principales: | Lim, Victoria M., Maranda, Eric L., Patel, Vivek, Simmons, Brian J., Jimenez, Joaquin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972728/ https://www.ncbi.nlm.nih.gov/pubmed/27289372 http://dx.doi.org/10.1007/s13555-016-0122-9 |
Ejemplares similares
-
Treatment-resistant prurigo nodularis
por: Kolli, Sree S, et al.
Publicado: (2019) -
Dermatoscopic Features of Prurigo Nodularis
por: Nair, Pragya A., et al.
Publicado: (2019) -
Treatment-resistant prurigo nodularis: challenges and solutions
por: Kowalski, Eric H, et al.
Publicado: (2019) -
Distinguishing truly recalcitrant prurigo nodularis from poor treatment adherence: a response to treatment-resistant prurigo nodularis [Response to letter]
por: Kowalski, Eric H, et al.
Publicado: (2019) -
Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series
por: Wieser, Jill K, et al.
Publicado: (2020)